Market Closed -
Australian S.E.
11:40:16 07/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.145
AUD
|
-3.33%
|
|
-3.33%
|
-27.50%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
135.2
|
276.8
|
471.3
|
276.2
|
309.7
|
92.44
|
-
|
-
|
Enterprise Value (EV)
1 |
110
|
205.4
|
415
|
237.2
|
276.1
|
75.85
|
78.36
|
68.61
|
P/E ratio
|
-28.7
x
|
-18.2
x
|
-26.3
x
|
-10.1
x
|
-
|
-
|
16.7
x
|
13.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.8
x
|
8.93
x
|
10.7
x
|
2.56
x
|
2.53
x
|
0.75
x
|
0.76
x
|
0.73
x
|
EV / Revenue
|
5.53
x
|
6.63
x
|
9.46
x
|
2.2
x
|
2.26
x
|
0.61
x
|
0.64
x
|
0.54
x
|
EV / EBITDA
|
-28.7
x
|
-30.5
x
|
-68.1
x
|
57.8
x
|
33.2
x
|
4.86
x
|
4.69
x
|
3.92
x
|
EV / FCF
|
-16.3
x
|
-15.1
x
|
-24.2
x
|
-1.62
x
|
-22.9
x
|
-7.16
x
|
17.4
x
|
10.9
x
|
FCF Yield
|
-6.13%
|
-6.61%
|
-4.13%
|
-61.8%
|
-4.36%
|
-14%
|
5.74%
|
9.18%
|
Price to Book
|
4.16
x
|
3.4
x
|
4.58
x
|
1.26
x
|
1.36
x
|
0.43
x
|
0.44
x
|
0.42
x
|
Nbr of stocks (in thousands)
|
2,59,937
|
3,76,562
|
4,15,221
|
5,52,350
|
6,07,253
|
6,16,253
|
-
|
-
|
Reference price
2 |
0.5200
|
0.7350
|
1.135
|
0.5000
|
0.5100
|
0.1500
|
0.1500
|
0.1500
|
Announcement Date
|
28/08/19
|
25/08/20
|
25/08/21
|
29/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
19.88
|
31.01
|
43.87
|
108
|
122.4
|
123.5
|
122.3
|
127.4
|
EBITDA
1 |
-3.84
|
-6.735
|
-6.09
|
4.106
|
8.323
|
15.6
|
16.7
|
17.5
|
EBIT
1 |
-4.3
|
-8.771
|
-8.707
|
-7.316
|
-11.59
|
0.7468
|
2.679
|
5.268
|
Operating Margin
|
-21.63%
|
-28.29%
|
-19.85%
|
-6.77%
|
-9.47%
|
0.6%
|
2.19%
|
4.13%
|
Earnings before Tax (EBT)
|
-4.046
|
-12.13
|
-15.03
|
-22.36
|
-
|
-
|
5.7
|
6.5
|
Net income
1 |
-4.132
|
-12.21
|
-13.89
|
-21.15
|
-23.87
|
-9.9
|
5.7
|
6.5
|
Net margin
|
-20.78%
|
-39.37%
|
-31.66%
|
-19.58%
|
-19.5%
|
-8.01%
|
4.66%
|
5.1%
|
EPS
|
-0.0181
|
-0.0403
|
-0.0431
|
-0.0494
|
-
|
-
|
0.009000
|
0.0110
|
Free Cash Flow
1 |
-6.749
|
-13.58
|
-17.15
|
-146.6
|
-12.05
|
-10.6
|
4.5
|
6.3
|
FCF margin
|
-33.95%
|
-43.81%
|
-39.1%
|
-135.7%
|
-9.85%
|
-8.58%
|
3.68%
|
4.94%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
26.95%
|
36%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
78.95%
|
96.92%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/08/19
|
25/08/20
|
25/08/21
|
29/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2020 S2
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-1.874
|
-4.861
|
-2.516
|
1.182
|
2.924
|
2.06
|
6.263
|
-
|
EBIT
|
-1.874
|
-6.897
|
-5.07
|
-3.43
|
-18.16
|
-2.305
|
-1.968
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-3.946
|
-
|
-
|
-10.51
|
-
|
-18.47
|
-
|
-
|
Net income
1 |
-3.996
|
-
|
-
|
-10.52
|
-
|
-18.18
|
-
|
-10.71
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.0177
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/02/20
|
25/08/20
|
25/08/21
|
24/02/22
|
29/08/22
|
26/02/23
|
30/08/23
|
27/02/24
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
25.1
|
71.4
|
56.3
|
39
|
33.6
|
16.6
|
14.1
|
23.8
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-6.75
|
-13.6
|
-17.2
|
-147
|
-12.1
|
-10.6
|
4.5
|
6.3
|
ROE (net income / shareholders' equity)
|
-18.3%
|
-22.1%
|
-15%
|
-3.84%
|
-6.84%
|
-0.64%
|
1.72%
|
3.55%
|
ROA (Net income/ Total Assets)
|
-11.6%
|
-10.2%
|
-10.9%
|
-9.43%
|
-4.86%
|
1.8%
|
1.8%
|
2%
|
Assets
1 |
35.64
|
120
|
127.3
|
224.3
|
491.2
|
-550
|
316.7
|
325
|
Book Value Per Share
2 |
0.1300
|
0.2200
|
0.2500
|
0.4000
|
0.3700
|
0.3500
|
0.3400
|
0.3600
|
Cash Flow per Share
|
-
|
-
|
-0.0300
|
-0
|
-
|
-
|
-
|
-
|
Capex
1 |
0.2
|
0.33
|
6.23
|
17.2
|
-
|
0.1
|
0.7
|
0.7
|
Capex / Sales
|
0.99%
|
1.06%
|
14.2%
|
15.94%
|
-
|
0.08%
|
0.57%
|
0.55%
|
Announcement Date
|
28/08/19
|
25/08/20
|
25/08/21
|
29/08/22
|
30/08/23
|
-
|
-
|
-
|
Last Close Price
0.15
AUD Average target price
0.39
AUD Spread / Average Target +160.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -27.50% | 61.2M | | +22.81% | 46.81B | | -1.88% | 41.37B | | +46.73% | 41.29B | | -6.20% | 28.87B | | +11.33% | 26.06B | | -21.00% | 19.13B | | +30.73% | 12.39B | | -0.48% | 12.08B | | -1.43% | 11.96B |
Other Biotechnology & Medical Research
|